Electrophysiology of postsynaptic activation

Annals of the New York Academy of Sciences

Volumn 841, Issue , 1998, Pages 57-70

  Ruff, Robert L ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; MESSENGER RNA; N ACETYL S NITROSOPENICILLAMINE; NICOTINIC RECEPTOR; SODIUM CHANNEL;

CONFERENCE PAPER; CYTOSKELETON; ELECTROPHYSIOLOGY; ENDPLATE POTENTIAL; FAST MUSCLE; HUMAN; MEMBRANE STRUCTURE; MUSCLE LENGTH; NERVE ENDING; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; NONHUMAN; POSTSYNAPTIC MEMBRANE; POSTSYNAPTIC POTENTIAL; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; SYNAPSE;

EID: 0031879687     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10909.x     Document Type: Conference Paper

References (79)

1. KAMINSKI, H. J. & R. L. RUFF. 1996. The myasthenic syndromes. In Physiology of Membrane Disorders. Volume 1, p. 565-593. Plenum. New York.
2. SALPETER, M. M. 1987. The Vertebrate Neuromuscular Junction. Alan R. Liss. New York.
3. KATZ, B. 1966. Nerve Muscle and Synapse. McGraw-Hill. New York.
4. KATZ, B. & R. MILEDI. 1972. The statistical nature of the acetylcholine potential and its molecular components. J. Physiol. (Lond.) 224: 665-699.
5. KATZ, B. & R. MILEDI. 1973. The binding of acetylcholine to receptors and its removal from the synaptic cleft. J. Physiol. (Lond.) 231: 549-574.
6. KATZ, B. & R. MILEDI. 1979. Estimates of quantal content during chemical potentiation of transmitter release. Proc. R. Soc. Lond. 205: 369-378.
7. MILEDI, R., P. C. MOLENAAR & R. L. POLAK. 1983. Electrophysiological and chemical determination of acetylcholine release at the frog neuromuscular junction. J. Physiol. (Lond.) 334: 245-254.
8. LAND, B. R., W. V HARRIS, E. E. SALPETER & M. M. SALPETER. 1984. Diffusion and binding constants for acetylcholine derived from the falling phase of miniature endplate currents. Proc. Natl. Acad. Sci. U.S.A. 81: 1594-1598.
9. MCMAHAN, U. J., J. R. SANES & L. M. MARSHALL. 1978. Cholinesterase is associated with the basal lamina at the neuromuscular junction. Nature 271: 172-174.
10. + current amplitude and excitability near and far from the end-plate. Muscle Nerve 19: 1084-1092.
11. + currents near and away from endplates on human fast and slow twitch muscle fibers. Muscle Nerve 16: 922-929.
12. KAMINSKI, H. J., J. I. SUAREZ & R. L. RUFF. 1997. Neuromuscular junction physiology in MG: isoforms of the acetylcholine receptor in extraocular muscle and the contribution of sodium channels to the safety factor. Neurology 48(suppl. 5): S8-S17.
13. + channels and ankyrin in neuromuscular junctions is complementary to that of acetylcholine receptors and the 43 kD protein. Neuron 3: 163-175.
14. LAND, B. R., E. E. SALPETER & M. M. SALPETER. 1981. Kinetic parameters for acetylcholine interaction in intact neuromuscular junction. Proc. Natl. Acad. Sci. U.S.A. 78: 7200-7204.
15. KUFFLER, S. W. & D. YOSHIKAMI. 1975. The distribution of acetylcholine sensitivity at the post-synaptic membrane of vertebrate skeletal twitch muscles: iontophoretic mapping in the micron range. J. Physiol. (Lond.) 244: 703-730.
16. MERLIE, J. P. & J. R. SANES. 1985. Concentration of acetylcholine receptor mRNA in synaptic regions of adult muscle fibers. Nature 317: 66-68.
17. SANES, J. R., Y. R. JOHNSON, P. T. KOTZBAUER, J. MUDD, T. HANLEY, J-C. MARTINOU & J. P. MERLIE. 1991. Selective expression of an acetylcholine receptor-lacZ transgene in synaptic nuclei of adult muscle fibers. Development 113: 1181-1191.
18. SALPETER, M. M. & R. H. LORING. 1985. Nicotinic acetylcholine receptors in vertebrate muscle: properties, distribution, and neural control. Prog. Neurobiol. 25: 297-325.
19. KARLIN, A. 1991. Explorations of the nicotinic acetylcholine receptor. Harvey Lect. 85: 71-107.
20. NUMA, S. 1989. A molecular view of neurotransmitter receptors and ionic channels. Harvey Lect. 83: 121-165.
21. WITZEMANN, V., B. BARG, Y. NISHIKAWA, B. SAKMANN & S. NUMA. 1987. Differential regulation of muscle acetylcholine receptor γ- and ε-subunit mRNAs. FEBS Lett. 223: 104-112.
22. WITZEMANN, V, B. BARG, M. CRIADO, E. STEIN & B. SAKMANN. 1989. Developmental regulation of five subunits specific mRNAs encoding acetylcholine receptor subtypes in rat muscle. FEBS Lett. 242: 419-424.
23. NODA, M., Y. FURUTANI, H. TAKAHASHI, M. TOYOSATO, T. TANADE, S. SHIMIZU, S. KIKYOTANI, T. KAYANO, T. HIROSE, S. INAYAMA & S. NUMA. 1983. Cloning and sequence analysis of calf cDNA and human genomic DNA encoding alpha-subunit precursor of muscle acetylcholine receptor. Nature 305: 818-823.
24. TARAI, T., M. NODA, M. MISHINA, S. SHIMIZU, Y. FURUTANI, T. KAYANO, T. IKEDA, K. TAI, H. TAKAHASHI, T. TAKAHASHI, M. KUNO & S. NUMA. 1985. Cloning, sequencing, and expression of cDNA for a novel subunit of acetylcholine receptor from calf muscle. Nature 315: 761-764.
25. MISHINA, M., T. TAKAI, K. IMOTO, M. NODA, T. TAKAHASHI, S. NUMA, C. METHFESSL & B. SAKMANN. 1986. Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature 321: 406-411.
26. FAMBROUGH, D. M., D. B. DRACHMAN & S. SATYAMURTI. 1973. Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors. Science 182: 293-295.
27. ENGEL, A. 1984. Myasthenia gravis and myasthenic syndrome. Ann. Neurol. 16: 519-534.
28. LINDSTROM, J. M., M. E. SEYBOLD, V A. LENNON, S. WHITTINGHAM & D. D. DUANE. 1976. Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value. Neurology 26: 1054-1059.
29. DRACHMAN, D. B. 1987. Myasthenia gravis: a model disorder of acetylcholine receptors. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 65: 65-82.
30. KAO, I. & D. DRACHMAN. 1977. Myasthenie immunoglobulin accelerates acetylcholine receptor degradation. Science 196: 526.
31. LINDSTROM, J. M., A. G. ENGEL, M. E. SEYBOLD, V. A. LENNON & E. H. LAMBERT. 1976. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with antiacetylcholine receptor antibodies. J. Exp. Med. 144: 739-753.
32. ENGEL, A. G. 1987. The molecular biology of end-plate diseases. In The Vertebrate Neuromuscular Junction. Volume 23, p. 361-424. Alan R. Liss. New York.
33. DRACHMAN, D., C. W. ANGUS, R. N. ADAMS & I. KAO. 1978. Effect of myasthenic patients' immunoglobulin on acetylcholine receptor turnover: selectivity of degradation process. Proc. Natl. Acad. Sci. U.S.A. 75: 3422-3426.
34. ENGEL, A. G. 1986. Myasthenic syndromes. In Myology, p. 1955-1990. McGraw-Hill. New York.
35. DRACHMAN, D. B. 1994. Myasthenia gravis. N. Engl. J. Med. 330: 1797-1810.
36. MERLIE, J. P., S. HEINEMANN & J. M. LINDSTROM. 1979. Acetylcholine receptor degradation in adult rat diaphragms in organ culture and the effect of anti-acetylcholine receptor antibodies. J. Biol. Chem. 254: 6320-6327.
37. ENGEL, A. G. & G. FUMAGALLI. 1982. Mechanisms of acetylcholine receptor loss from the neuromuscular junction. Ciba Found. Symp. 90: 197-224.
38. ASHER, O., D. NEUMANN, V. WITZEMANN & S. FUCHS. 1990. Acetylcholine receptor gene expression in experimental autoimmune myasthenia gravis. FEBS Lett. 261: 231-235.
39. RUFF, R. L. 1986. Ionic channels: I. The biophysical basis for ion passage and channel gating. Muscle Nerve 9: 675-699.
40. FROEHNER, S. C. 1991. The submembrane machinery for nicotinic acetylcholine receptor clustering. J. Cell Biol. 114: 1-7.
41. APEL, E. D., S. L. ROBERDS, K. P. CAMPBELL & J. P. MERLIE. 1995. Rapsyn may function as a link between the acetylcholine receptor and the agrin-binding dystrophin-associated glycoprotein complex. Neuron 15: 115-126.
42. SADOULET-PUCCIO, H. M., T. S. KHURANA, J. B. COHEN & L. M. KUNKEL. 1996. Cloning and characterization of the human homologue of a dystrophin-related phosphoprotein found at the Torpedo electric organ post-synaptic membrane. Hum. Mol. Genet. 5: 489-496.
43. OHLENDIECK, K. 1996. Towards an understanding of the dystrophin-glycoprotein complex: linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibers. Eur. J. Cell Biol. 69: 1-10.
44. CAMPBELL, K. P. & R. H. CROSBIE. 1996. Utrophin to the rescue. Nature 384: 308-309.
45. KLEIMAN, R. J. & L. F. REICHARDT. 1996. Testing the agrin hypothesis. Cell 85: 461-464.
46. BRENMAN, J. E., D. S. CHAD, S. H. GEE, A. W. MCGEE, S. E. CRAVEN, D. B. SANTILLANO, Z. WU, F. HUANG, H. XIA, M. F. PETERS, S. C. FROEHNER & D. S. BREDT. 1996. Interaction of nitric oxide synthase with the postsynaptic protein PSD-95 and α1-syntrophin mediated by PDZ domains. Cell 84: 757-767.
47. CAMPBELL, K. P. 1995. Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 80: 675-679.
48. MARTINOU, J-C., D. I. FALLS, G. D. FISCHBACH & J. P. MERLIE. 1991. Acetylcholine receptor-inducing activity stimulates expression of the epsilon-subunit gene of the muscle acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A. 88: 7669-7673.
49. DUGGAN, D. J., J. R. GOROSPE, M. FANIN, E. P. HUFFMAN & C. ANGELINI. 1997. Mutations in the sarcoglycan genes in patients with myopathy. N. Engl. J. Med. 336: 618-624.
50. COLQUHOUN, D. & B. SAKMANN. 1985. Fast events in single-channel currents activated by acetylcholine and its analogues at the frog muscle end-plate. J. Physiol. (Lond.) 369: 501-557.
51. HAIMOVICH, B., D. L. SCHOTLAND, W. E. FIELES & R. L. BARCHI. 1987. Localization of sodium channel subtypes in rat skeletal muscle using channel-specific monoclonal antibodies. J. Neurosci. 7: 2957-2966.
52. RUFF, R. L. 1992. Na current density at and away from end plates on rat fast- and slowtwitch skeletal muscle fibers. Am. J. Physiol. 262(Cell. Physiol. 31): C229-C234.
53. + current densities and voltage dependence in human intercostal muscle fibres. J. Physiol. (Lond.) 458: 85-97.
54. + currents from type IIa and IIb human intercostal muscle fibers. Am. J. Physiol. 265(Cell. Physiol. 34): C171-C177.
55. + channels are localized and immobilized to synapses of innervated muscle fibres. Nature 321: 63-66.
56. ALMERS, W, P. R. STANFIELD & W. STÜILMER. 1983. Lateral distribution of sodium and potassium channels in frog skeletal muscle: measurements with a patch-clamp technique. J. Physiol. (Lond.) 336: 261-284.
57. RUFF, R. L. 1996. Sodium channel slow inactivation and the distribution of sodium channels on skeletal muscle fibres enable the performance properties of different skeletal muscle fibre types. Acta Physiol. Scand. 156: 159-168.
58. Jo, S. A., X. ZHU, M. A. MARCHIONNI & S. J. BURDEN. 1995. Neuregulins are concentrated at nerve-muscle synapses and activate ACh-receptor gene expression. Nature 373: 158-161.
59. HALL, Z. W. 1992. The nerve terminal. In An Introduction to Molecular Neurobiology, p. 148-180. Sinauer Assoc. Sunderland, Massachusetts.
60. KUSHNER, L. L. & H. J. KAMINSKI. 1996. Nitric oxide synthase is concentrated at the skeletal muscle endplate. Brain Res. 730: 238-242.
61. SCHUMAN, E. M. & D. V. MADISON. 1994. Nitric oxide and synaptic function. Annu. Rev. Neurosci. 17: 153-183.
62. BREDT, D. S. & S. H. SNYDER. 1992. Nitric oxide, a novel neuronal messenger. Neuron 8: 3-11.
63. WANG, T., Z. XIE & B. LU. 1995. Nitric oxide mediates activity-dependent synaptic suppression at developing neuromuscular synapses. Nature 374: 262-266.
64. BANKER, B. Q., S. S. KELLY & N. ROBBINS. 1983. Neuromuscular transmission and correlative morphology in young and old mice. J. Physiol. (Lond.) 339: 355-375.
65. GERTLER, R. A. & N. ROBBINS. 1978. Differences in neuromuscular transmission in red and white muscles. Brain Res. 142: 255-284.
66. PADYKULA, H. A. & G. F. GAUTHIER. 1970. The ultrastructure of the neuromuscular junctions of mammalian red, white, and intermediate skeletal muscle fibers. J. Cell Biol. 46: 27-41.
67. TONGE, D. A. 1974. Chronic effects of botulinum toxin on neuromuscular transmission and sensitivity to acetylcholine in slow and fast skeletal muscle of the mouse. J. Physiol. (Lond.) 241: 127-139.
68. STERZ, R., M. PAGALA & K. PEPER. 1983. Postjunctional characteristics of the endplates in mammalian fast and slow muscles. Pflügers Arch. 398: 48-54.
69. STORELLA, R. J., W. F. RIKER & T. BAKER. 1985. d-Tubocurarine sensitivities of fast and slow neuromuscular system of the rat. Eur. J. Pharmacol. 118: 181-184.
70. MILTON, R. L., M. T. LUPA & J. H. CALDWELL. 1992. Fast and slow twitch skeletal muscle fibers differ in their distributions of Na channels near the endplate. Neurosci. Lett. 135: 41-44.
71. CALDWELL, J. H. & R. L. MILTON. 1988. Sodium channel distribution in normal and denervated rodent and snake skeletal muscle. J. Physiol. (Lond.) 401: 145-161.
72. CALDWELL, J. H., D. T. CAMPBELL & K. G. BEAM. 1986. Sodium channel distribution in vertebrate skeletal muscle. J. Gen. Physiol. 87: 907-932.
73. HENNIG, R. & T. LOMO. 1985. Firing patterns of motor units in normal rats. Nature 314: 164-166.
74. LEV-TOY, A. 1987. Junctional transmission in fast- and slow-twitch mammalian muscle units. J. Neurophysiol. 57: 660-671.
75. RUFF, R. L. & L. CORSILLO. 1994. Sodium channels near the endplate are lost in myasthenia gravis. Neurology 44: A189.
76. LINDSTROM, J. M., B. L. EINARSON, V A. LENNON & M. E. SEYBOLD. 1976. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and anti-receptor complexes from muscle of rats with experimental autoimmune myasthenia gravis. J. Exp. Med. 144: 726-738.
77. LENNON, V A. & E. H. LAMBERT. 1980. Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors. Nature 285: 238-240.
78. LENNON, V. A., M. E. SEYBOLD, J. M. LINDSTROM, C. COCHRANE & R. ULEVITCH. 1978. Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis. J. Exp. Med. 147: 973-983.
79. RUFF, R. L. 1996. Action potential thresholds are elevated near the end-plate, but not elsewhere in myasthenia gravis and passive transfer experimental myasthenia gravis. Ann. Neurol. 40: 507-508.